title: Atrial natriuretic factor secretion: a role for atrial systolic ejection force?
abstract: The increase in plasma concentration of atrial natriuretic factor in heart transplant patients has not been fully elucidated. Besides an eventual pressure or volume overload leading to passive atrial distension, the atrial tension developed during atrial systole, or atrial ejection force, which may be increased by the transplantation procedure, is an important determinant of atrial natriuretic factor release. We therefore determined the plasma concentration of atrial natriuretic factor and the maximal atrial ejection force in 15 heart transplant patients and 8 controls, matched for age and body mass. Atrial ejection force, as defined as the force exerted by the left atrium to accelerate blood into the left ventricle during atrial systole, was obtained using combined two-dimensional imaging and doppler echocardiography. Serum creatinin concentrations, heart rate [91.9 (SD 13.2) vs 71.8 (SD 10.9) beats.min-1], mean arterial blood pressure [103.9 (SD 9.8) vs 87.4 (SD 5.8) mmHg, 13.85 (SD 1.31) vs 11.65 (SD 0.77) kPa], left ventricular posterior wall thickness and interventricular septum thickness were higher in heart transplant patients compared to controls. Plasma concentration of atrial natriuretic factor was also elevated in heart transplant patients [63.9 (SD 18.1) vs 34.0 (SD 3.2) pg.ml-1; P < 0.001]. In contrast, although the left atrial area was greater in heart transplant patients [28.2 (SD 4.8) vs 15.8 (SD 2.5) cm2; P < 0.001], mitral area, transmitral Doppler A-wave maximal velocity and atrial ejection force were similar in transplant and in control patients [7.7 (SD 3.5) vs 8.9 (SD 2.8) kdyn, 77 (SD 35) vs 89 (SD 28)mN]. No significant correlation was observed between concentration of atrial natriuretic factor and atrial ejection force, either in heart transplant patients or in controls. Thus, the elevated plasma concentration of atrial natriuretic factor observed in these heart transplant patients was multifactorial in origin, and was considered to depend upon an hypersecretion rather than upon a decreased clearance rate. Moreover, it is suggested that the atrial ejection force was unlikely to have participated in this enhanced release of atrial natriuretic factor.
authors.affiliation: Laboratoire d'Explorations Fonctionnelles du Système Circulatoire, Faculté de Médecine Strasbourg, France.
authors.forename: B
authors.initials: B
authors.lastname: Geny
authors.forename: F
authors.initials: F
authors.lastname: Piquard
authors.forename: M
authors.initials: M
authors.lastname: Follenius
authors.forename: H
authors.initials: H
authors.lastname: Petit
authors.forename: F
authors.initials: F
authors.lastname: Levy
authors.forename: E
authors.initials: E
authors.lastname: Epailly
authors.forename: J G
authors.initials: JG
authors.lastname: Kretz
authors.forename: B
authors.initials: B
authors.lastname: Eisenmann
authors.forename: P
authors.initials: P
authors.lastname: Haberey
mesh_terms: D000328:Adult; D016275:Atrial Function; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013318:Stroke Volume / Q000502:physiology; D014463:Ultrasonography
chemical_list: D009320:Atrial Natriuretic Factor